On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayJul 25, 2019 2:53 pm

QualityStocksNewsBreaks – Why ORHub Inc. (ORHB) Is ‘One to Watch’

ORHub (OTC: ORHB) is a healthcare data analytics company focused on enhancing the business of surgery through lean process advancement. A recent article discussing the company reads, “ORHub’s Surgical Spotlight(R) is a cloud-based analytics tool that helps administrators, nurse leaders and surgeons make improved business decisions for the operating room. By taking data feeds from the facility’s Operating Room Information System, ORHub produces a functional and elegant dashboard that allows users to easily identify opportunities for improvement. . . . These capabilities allow providers to harness data, identify millions of dollars in opportunities, and get leaders back to their primary…

Continue Reading

TuesdayJul 23, 2019 3:08 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Joint Development Agreement to Create Biosynthesis Platform for CBD Production, Distribution

Willow Biosciences (CSE: WLLW) recently entered a joint development agreement (“JDA”) with leading cannabinoid manufacturer Noramco Inc. to develop a yeast-based biosynthesis platform for the production and distribution of cannabidiol (“CBD”) (http://ibn.fm/8F330). An article further discussing the company reads, “The JDA is mutually exclusive and creates an enviable arrangement designed to take advantage of each company’s unique and compelling skill sets, the news release notes. The JDA requires each company to cover its own costs, retain its own intellectual property associated with its own scopes of work and share equally in the gross profits from sales of CBD produced under…

Continue Reading

TuesdayJul 23, 2019 2:51 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Remains Ahead of the Pack with Innovative Delivery Technology

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is the developer of the drug-delivery platform DehydraTECH(TM). The company’s innovative technology promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. An article discussing the company reads, “One of the delivery challenges is the amount of CBD waste created, because the human body can only absorb a small amount of the molecules. DehydraTECH is disrupting this cycle by protecting the product during stomach transit, amplifying intestinal absorption by five to ten times over traditional methods and enabling the drug to bypass first-pass liver metabolism. Third-party lab studies…

Continue Reading

TuesdayJul 23, 2019 2:04 pm

QualityStocksNewsBreaks – Sharing Services Inc. (SHRG) Capitalizing on New Direct-Selling Opportunities Driven by Changing Retail Industry

Sharing Services Global Corporation (OTCQB: SHRG) is a multimillion-dollar operation that utilizes a home-based business entrepreneurship model. An article discussing the company reads, “A quick search of the retail industry suggests that the sector is dying, as stores such as Payless, Walgreens, JCPenney, Victoria Secret and more announce closures. However, a closer look reveals that the industry is not dying; it is merely changing. People are skipping crowded malls and shops and opting for the ease of e-commerce and the comfort of direct selling. According to Statista, the direct-selling market brought in $64 billion in the Americas, with wellness products…

Continue Reading

TuesdayJul 23, 2019 2:00 pm

QualityStocksNewsBreaks – Endonovo Therapeutics Inc.’s (ENDV) SofPulse Safely Reduces Pain, Swelling

Endonovo Therapeutics (OTCQB: ENDV) is a commercial-stage developer of noninvasive Electroceutical(TM) Therapeutic devices that target patient pain and inflammation while supporting wound recovery. An article discussing the company reads, “Targeting inflammatory conditions in vital organs and peripheral tissues, Endonovo’s SofPulse(R) is clinically proven to significantly speed the recovery process and reduce the need for potentially addictive pain medications, thereby improving the patient’s natural recovery experience (http://ibn.fm/qHmMQ). . . . The efficacy of SofPulse targeted pulsed electromagnetic field therapy (tPEMF), which uses targeted microcurrents to transmit gentle pulses to the tissue, is well documented and supported by peer-reviewed clinical research. Among the…

Continue Reading

TuesdayJul 23, 2019 12:09 pm

QualityStocksNewsBreaks – Supreme Cannabis Company Inc.’s (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) New Investment Platform Targets UK, European CBD Health and Wellness Sector

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) recently launched a new investment platform called Supreme Heights. Established in London, the platform will capitalize on opportunities within the UK and European CBD health-and-wellness space. An article discussing the company reads, “While Supreme Heights has been initiated as a separate entity, the platform has solid foundational support and will benefit from Supreme Cannabis’ regulatory, product commercialization, supply chain, marketing and capital markets expertise, as well as corporate support services (http://ibn.fm/Fsts5). Additionally, Supreme Heights will benefit from Supreme Cannabis’ experience launching premium brands and its team’s history of supporting health and…

Continue Reading

FridayJul 19, 2019 3:44 pm

QualityStocksNewsBreaks – Hemptown USA Employs Strategic Hemp-Cultivation Methodology to Increase Yields, Lower Costs

Hemptown USA is employing technology to improve hemp cultivation by keeping production costs low and optimizing yields. An article discussing the company reads, “Hemptown employs a ‘soil to oil’ methodology that involves experienced professionals working in a few selected agricultural microclimates across Oregon’s Emerald Triangle, Kentucky and Colorado. In 2018, Hemptown harvested 110,000 pounds of full-spectrum biomass with CBD content of approximately 17% from the Oregon hemp farm. . . . In 2019, the company is scaling up operations to meet the growing market demand for affordable hemp and CBD oil. As per initial estimates, it will cultivate over one…

Continue Reading

FridayJul 19, 2019 2:58 pm

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Aims to Establish Significant Presence in Global Hemp, CBD Market

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An article discussing the company’s entrance into the global hemp-CBD market reads, “TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to…

Continue Reading

FridayJul 19, 2019 2:41 pm

QualityStocksNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Swiftly Expanding Throughout the US

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3), a company with roots as a family-run business selling vape pens in Washington state, has transformed into an award-winning cannabis holding company with a multistate portfolio. An article discussing the company reads, “Headquartered in Washington, where it all began, the company is rapidly expanding throughout the United States, reaching first into Oregon, California and Nevada, with its products currently sold in 685 stores across six states, and plans in place to continue expansion into other states throughout the year. The company is focused on organic, bottom-up growth as it cultivates and delivers…

Continue Reading

FridayJul 19, 2019 1:18 pm

QualityStocksNewsBreaks – INmune Bio Inc.’s (NASDAQ: INMB) Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease

INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An association between inflammation and Alzheimer’s disease has long been established. Until present, however, this link and the way in which it could be used to offer reliable AD treatments have both been overlooked. Numerous inflammatory markers are found in AD patients, and several studies establish a link between chronic inflammation and the development of AD. . . . XPro1595 works by targeting the microglial immune…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered